Canlyniadau Chwilio am Awdur :: Library Catalog

1

$Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

$Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

$Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

$Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

$Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

$Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates gan Evan C. Chen (15054014)

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States gan Laura E. Stevens (14961009)

Offerynnau Chwilio: